A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

1. López-Guillermo, A.
2. Canales, M.Á.
3. Dlouhy, I.
4. Mercadal, S.
5. Briones, J.
6. Martín García-Sancho, A.
7. Sancho, J.M.
8. Moraleda, J.M.
9. Terol, M.J.
10. Salar, A.
11. Palomera, L.
12. Gardella, S.
13. Jarque, I.
14. Ferrer, S.
15. Bargay, J.
16. López, A.
17. Panizo, C.
18. Muntañola, A.
19. Montalbán, C.
20. Conde, E.
21. Hernández, M.T.
22. Soler, A.
23. García Marco, J.A.
24. Deben, G.
25. Marín, J.
26. Tomás, J.F.
27. Mostrar todos los/as autores/as +